XM does not provide services to residents of the United States of America.

Chinese insurance broker Yuanbao files for US IPO amid reviving investor appetite



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>Chinese insurance broker Yuanbao files for US IPO amid reviving investor appetite</title></head><body>

Sept 17 (Reuters) -Chinese insurance broker Yuanbao on Tuesday filed for an initial public offering in the United States, signaling a broader recovery in investor appetite for new listings.


WHY IT'S IMPORTANT

IPOs in the U.S. are experiencinga reasonably stronger year after a prolonged dry spell as more companies test the market, encouraged by thestrong performance of high-profile listings like Reddit RDDT.N, alongside a rally in equities.

But, the number of IPOs by China-based companies in the U.S. has come down significantly in the last several years, after Beijing clamped down on offshore capital raising in 2021.

EV maker Zeekr's ZK.N debut on the New York Stock Exchange earlier this year was the first big listing by a Chinese company in the U.S. since ride-hailing giant Didi Global was forced to delist its shares in late 2021 following a backlash from Chinese regulators.


CONTEXT

Yuanbao is an online insurance distributor in China, that uses data and artificial intelligence to provide customizable insurance plans to its customers.

The company is the largest independent insurance distributor in China's personal life and accident and health (A&H) insurance market in terms of first-year premiums in 2023, the company said in its IPO filing.

Goldman Sachs, Citigroup and CICC are the lead underwriters for the offering.


BY THE NUMBERS

Yuanbao's full-year revenue rose to 2.05 billion Chinese yuan ($289.02 million) in 2023, compared to 850.3 million Chinese yuan a year earlier, the company said.

The company's first-year premiums more than doubled to 17.6 billion Chinese yuan ($2.48 billion) in 2023, from 8.5 billion Chinese yuan in the year-ago period.


WHAT'S NEXT

Yuanbao, which did not reveal the terms of its offering, is planning to list American depositary shares (ADS) on the Nasdaq under the ticker symbol "YB".


($1 = 7.0930 Chinese yuan renminbi)



Reporting by Jaiveer Singh Shekhawat in Bengaluru; Editing by Tasim Zahid

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.